topic

859 Regression of an immunologically ‘cold’ oral cancer model induced by modulation of the tumor microenvironment with DOXIL, anti-CTLA-4, and radiation
Fabio Henrique Brasil Da Costa, Rohan Bhavane, Ratna Veeramachaneni, Sofia Cortes, Sarah L Latka, Andrew Badachhape, Renuka TR Menon, Prajwal Bhandari, Ketankumar B Ghaghada, Simon Young, Ananth V Annapragada, Andrew Sikora

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A957; DOI: 10.1136/jitc-2023-SITC2023.0859
860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition
Maud Charpentier, Nils-Petter Rudqvist, Sheila Spada, Xi Zhou, Tuo Zhang, Silvia Formenti, Sandra Demaria

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A958-A959; DOI: 10.1136/jitc-2023-SITC2023.0860
861 Fractionated irradiation activates glioma immune microenvironment and boosts antigen-specific T cell response in experimental gliomas
Nirmeen Elmadany, Julius Michel, Jana Sonner, Svetlana Ovchinnikova, Khwab Sanghvi, Isabelle Bernhardt, Xin-Wen Zhang, Kristine Jähne, Ankita Sati, Simon Anders, Michael Breckwoldt, Michael Platten, Katharina Sahm

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A960; DOI: 10.1136/jitc-2023-SITC2023.0861
862 TLR9 agonism promotes cytotoxic T cell persistence and myeloid remodeling when combined with radiation therapy and PD-1 blockade in oligometastatic prostate cancer patients
Zenghua Fan, David Y Oh, Anthony Wong, Katsuto Shinohara, Hao Nguyen, Caleb Hwang, Hewitt Chang, Alec Starzinski, Tony Li, Christopher De Leon, Marissa Gin, Eliezer Van Allen, Li Zhang, Rahul R Aggarwal, Terence W Friedlander, Eric J Small, Felix Y Feng, Lawrence Fong

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A961; DOI: 10.1136/jitc-2023-SITC2023.0862
863 Novel radioimmunotherapy for lung cancer: a tumor targeting approach
Céline Godfroid, Jackeline Romero, Vincent Roh, Tania Wyss, Sara Labiano, Christian Klein, Laura Codarri Deak, Pablo Umaña, Genrich V Tolstonog, Christine Trumpfheller, Marie-Catherine Vozenin, Pedro Romero

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A962; DOI: 10.1136/jitc-2023-SITC2023.0863
864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation
Avijit Goswami, Sandeep Goyal, Princy Khurana, Kawaljit Singh, Ishani Ghoshal, Aditya Kulkarni

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A963; DOI: 10.1136/jitc-2023-SITC2023.0864
865 Combining radiotherapy with novel TLR-based immunotherapy for improved tumor control in lung cancer
Ryma Haroun, Juan Pablo Ordoñez, Ayman J Oweida

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A964; DOI: 10.1136/jitc-2023-SITC2023.0865
866 The effect of butyrophilin 1A1 blockade in combination with radiation treatment in colon and Lewis lung carcinoma
Steven H Lin, Stephen S Yoo, Nan Li

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A965; DOI: 10.1136/jitc-2023-SITC2023.0866
867 Embedding partial SBRT in low-dose radiotherapy (EclipseRT) plus immune checkpoint inhibitors for bulky tumors: a preclinical and clinical study
Ren Luo, Min Yu, Zhou Su, Kai Kang, You Lu

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A966; DOI: 10.1136/jitc-2023-SITC2023.0867
868 Antibody blockade of the mono-ADP-ribosyltransferase ART1 promotes radiation-induced tumour infiltration of dendritic cells and potentiates tumour control by radiotherapy and CTLA-4 inhibition
Ricardo M Sainz, Sumit Mukherjee, Jorge Humberto Rodriguez Quintero, Qingyang Zhang, Brendon M Stiles, Erik Wennerberg

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A967; DOI: 10.1136/jitc-2023-SITC2023.0868

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages